Read the latest issue of Drug Discovery World!
https://t.co/Z5ghNldaIa
Follow DDW; Business insights for the global scientific community
#DrugDiscovery
New vodcast: Sitting Down With… Derek Chen, ProBio
https://t.co/6PsB4sSZUD
Follow DDW; Business insights for the global scientific community
#DrugDiscovery
Women leading in biopharma: Charlotte Edenius, Gesynta
https://t.co/z857SrjrW2
Follow DDW; Business insights for the global scientific community
#Biopharma
Your infinite program team: How AI agents are accelerating R&D
Register for free now to secure your place!
Europe
https://t.co/MiUtanOaIG
Americas
https://t.co/36My2NxMON
Supported by @benchling#DrugDiscovery
The latest breakthroughs in cell & gene therapies
Read now:
https://t.co/E00jQVL64G
Follow DDW; Business insights for the global scientific community
Brought to you by @aldevron#CGT
FDA approves obinutuzumab for rare autoimmune disease
https://t.co/sCbxVwmUtw
Follow DDW; Business insights for the global scientific community
#AutoimmuneDisease
BII scales up and supports record-high number of new startups
https://t.co/bakJeZ0oxW
Follow DDW; Business insights for the global scientific community
#DrugDiscovery
Breye raises €67.5 million for retinal disease therapies
https://t.co/Wx4tC9nGrU
Follow DDW; Business insights for the global scientific community
#Ophthalmology
Pharma urges leaders to reverse Europe’s declining competitiveness
https://t.co/w2jYQFR77R
Follow DDW; Business insights for the global scientific community
#Pharma
$1 million Stephenson Global Prize honours pioneering KRAS research
https://t.co/nxyDNtszGl
Follow DDW; Business insights for the global scientific community
#CancerResearch
Phase III study supports lumateperone use in bipolar mania
https://t.co/GBB2PXwlWM
Follow DDW; Business insights for the global scientific community
#Neuroscience
Six reasons to register for Drug Discovery Innovators & Investors UK Conference
https://t.co/DWYhm9AOrD
Follow DDW; Business insights for the global scientific community
#DDII#DrugDiscovery
EC approves first triple-combination therapy for asthma maintenance
https://t.co/bxe61x7CXc
Follow DDW; Business insights for the global scientific community
#Asthma
Antibody engineering after generative AI: solving the validation bottleneck
https://t.co/qwlaR9JktL
Follow DDW; Business insights for the global scientific community
#Antibodies
Accelerating drug discovery with rational design
Download eBook:
https://t.co/PDZFsRYhkX
Brought to you by @thermofisher
Follow DDW; Business insights for the global scientific community
#DrugDiscovery
Novartis faces September’s fourth trial disappointment with ALS drug
https://t.co/cWQ1RjktDx
Follow DDW; Business insights for the global scientific community
#ALS
Scottish deep-tech company secures £22 million in grants
https://t.co/28F9IKzO9N
Follow DDW; Business insights for the global scientific community
#DeepTech
New deals boost Novo Nordisk’s AI drug discovery ambitions
https://t.co/TsZc2QTzOp
Follow DDW; Business insights for the global scientific community
#DrugDiscovery
Tackling drug discovery challenges in cancer research
September 24, 7 am PDT / 10 am EDT / 3 pm BST / 4 pm CEST
Register for free!
https://t.co/00MHGS3KJN
Co-sponsored by @BioIVT and @SartoriusGlobal#CancerResearch
Deep Science Ventures veterans launch Big Picture Bio
https://t.co/mfJGmdSRld
Follow DDW; Business insights for the global scientific community
#Oncology